Five-Year Outcomes of Proton Therapy in Localized Prostate Cancer on 3 Prospective Trials for Low-, Intermediate-, and High-Risk Prostate Cancer

被引：1
|
作者：
Mendenhall, N. P. [1 ]
Hoppe, B. S. [1 ]
Morris, C. G. [1 ]
Nichols, R. C. [1 ]
Mendenhall, W. M. [1 ]
Su, Z. [1 ]
Li, Z. [1 ]
Williams, C. R. [2 ]
Costa, J. [2 ]
Henderson, R. H. [1 ]
机构：
[1] Univ Florida, Proton Therapy Inst, Jacksonville, FL USA
[2] Univ Florida, Coll Med, Dept Surg, Div Urol, Jacksonville, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2013年 / 87卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2013.06.400
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [1] Localized intermediate- to high-risk prostate cancer
    Tritschler, S.
    Ganswindt, U.
    Stief, C. G.
    UROLOGE, 2016, 55 (03): : 318 - +
  • [2] Five-Year Outcomes from 3 Prospective Trials of Image-Guided Proton Therapy for Prostate Cancer
    Mendenhall, Nancy P.
    Hoppe, Bradford S.
    Nichols, Romaine C.
    Mendenhall, William M.
    Morris, Christopher G.
    Li, Zuofeng
    Su, Zhong
    Williams, Christopher R.
    Costa, Joseph
    Henderson, Randal H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (03): : 596 - 602
  • [3] Molecular correlates of intermediate- and high-risk localized prostate cancer
    Ye, Huihui
    Sowalsky, Adam G.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 368 - 374
  • [4] Focal therapy in intermediate- and high-risk prostate cancer
    Huebner, Nicolai A.
    Korn, Stephan
    Rajwa, Pawel
    Shariat, Shahrokh F.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (04) : 247 - 250
  • [5] Focal therapy in intermediate- and high-risk prostate cancer
    Nicolai A. Huebner
    Stephan Korn
    Pawel Rajwa
    Shahrokh F. Shariat
    memo - Magazine of European Medical Oncology, 2023, 16 : 247 - 250
  • [6] Proton Beam Therapy Alone for Intermediate- or High-Risk Prostate Cancer: An Institutional Prospective Cohort Study
    Arimura, Takeshi
    Yoshiura, Takashi
    Matsukawa, Kyoo
    Kondo, Naoaki
    Kitano, Ikumi
    Ogino, Takashi
    CANCERS, 2018, 10 (04)
  • [7] Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer
    Bryant, Alex K.
    McKay, Rana R.
    Kader, A. Karim
    Parsons, J. Kellogg
    Einck, John P.
    Kane, Christopher J.
    Mundt, Arno J.
    Murphy, James D.
    Rose, Brent S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : 1068 - 1076
  • [8] The role of proton beam therapy for patients with intermediate- and high-risk prostate cancer.
    Arimura, Takeshi
    Kondo, Naoaki
    Matsukawa, Kyoko
    Wada, Kiyotaka
    Kitano, Ikumi
    Chuman, Ikuko
    Nagata, Ichiro
    Ogino, Takashi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [9] Management trends in the United States for low-, intermediate-, and high-risk prostate cancer.
    Ahmed, Kamran A.
    Kim, Jongphil
    Biagioli, Matthew C.
    Fernandez, Daniel Celestino
    Pow-Sang, Julio
    Poch, Michael Adam
    Wilder, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Five-Year Outcomes From a Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
    Meier, R.
    Beckman, A.
    Henning, G.
    Mohideen, N.
    Woodhouse, S. A.
    Cotrutz, C.
    Kaplan, I. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S33 - S34
12345